NRX Pharmaceuticals, Inc. (NRXP) Insider Ownership

Historic Insider Ownership Trends

According to recent filings covering the 90 days ending February 19, 2026, the three most significant insider holders at NRX Pharmaceuticals are Chairman And Chief Scientist Jonathan C Javitt (1.37Mn shares), TenPercentOwner Daniel C. Javitt (963.48K shares), Director Chaim Hurvitz (77.84K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Jonathan C Javitt Chairman And Chief Scientist 1,374,634 18 Dec, 2024
Daniel C. Javitt 963,479 01 Dec, 2022
Chaim Hurvitz 77,844 11 Sep, 2023
Lending Group Llc Brac 59,044 04 Jun, 2021
Rock Partners Sponsor, Llc Big 51,932 25 May, 2021
Aaron Gorovitz 10,500 11 Sep, 2023
Voorhees Seth Van Chief Financial Officer 6,271 19 Dec, 2022
Stephen H Willard Chief Executive Officer 5,000 19 Dec, 2022
Daniel Troy 4,309 10 Jun, 2021
Patrick John Flynn 4,196 29 Nov, 2022
Alessandra Daigneault General Counsel & Secretary 3,158 02 Nov, 2021
Herbert Raymond Mcmaster 1,830 02 Nov, 2021
Sharon Glied 1,317 10 Jun, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
17 Dec, 2024 Jonathan C Javitt Common Stock A 40,000 $1.17 84,634 D P
30 Aug, 2023 Chaim Hurvitz Common Stock, par value $0.001 per share A 70,000 $0.29 57,000 D P
30 Aug, 2023 Aaron Gorovitz Common Stock, par value $0.001 per share A 35,000 $0.32 10,500 I P
30 Aug, 2023 Aaron Gorovitz - - 10,500 I
23 Aug, 2023 Jonathan C Javitt Common Stock A 100,000 $0.33 44,633 D P
22 Aug, 2023 Jonathan C Javitt Common Stock A 200,000 $0.32 34,633 D P
16 Dec, 2022 Voorhees Seth Van Common Stock, par value $0.001 per share A 30,000 $1.10 4,634 D P
16 Dec, 2022 Stephen H Willard - - 5,000 D
16 Dec, 2022 Stephen H Willard Common Stock, par value $0.001 per share A 50,000 $1.17 5,000 D P
07 Dec, 2022 Jonathan C Javitt Common Stock, par value $0.001 per share D 400,000 $1.00 1,290,000 I S
07 Dec, 2022 Jonathan C Javitt - - 1,290,000 I
30 Nov, 2022 Daniel C. Javitt common stock D 8,441 $1.50 963,479 I S
30 Nov, 2022 Daniel C. Javitt - - 963,479 I
29 Nov, 2022 Daniel C. Javitt common stock D 13,730 $1.50 964,323 I S
28 Nov, 2022 Patrick John Flynn - - 175 D
28 Nov, 2022 Patrick John Flynn - - 3,771 I
28 Nov, 2022 Patrick John Flynn Common Stock, par value $0.001 per share A 2,500 $1.25 3,771 I P
28 Nov, 2022 Patrick John Flynn Common Stock, par value $0.001 per share A 1,750 $1.25 175 D P
28 Nov, 2022 Patrick John Flynn - - 4,021 I
28 Nov, 2022 Patrick John Flynn - - 3,771 I